Health in Kazakhstan 1,350 indicators covering health for Kazakhstan. IndicatorLatest Year10-yr change Rank Cholera case fatality rate 0 2008 — 37th Constant stillbirth rate 4.29 2030 unchanged 147th ENAP target met stillbirth rate 2.99 2030 down 26.7% 157th Stillbirth rate high-income country 2.8 2030 down 30.7% 1st Stillbirths remain constant projection 1,670 2030 down 3.6% 83rd Stillbirth maintained projection 1,161 2030 down 29.5% 87th Stillbirth ENAP 2030 target met projection 1,161 2030 down 29.5% 84th Stillbirth high-income country average rate matched projection 1,087 2030 down 33.3% 63rd Stillbirth rate current trends 2.99 2030 down 26.7% 157th Life satisfaction vs life expectancy 74.4 2023 up 5.2% 124th Estimate of current cigarette smoking prevalence 16.2% 2030 down 20.6% 61st Estimate of current cigarette smoking prevalence (%) 16.8% 2030 down 18.4% 59th Tb patients tested positive for hiv 625 2021 up 77.6% 49th Number of children aged 6-59 months with anaemia 447.1 2019 up 8.5% 73rd Prevalence of anaemia in children aged 6-59 months 23.0% 2019 down 15.4% 118th Number of deaths attributed to non-communicable diseases, by type of 21,876 2019 down 3.2% 53rd Hepatitis B surface antigen (HBsAg) prevalence 0.2% 2024 unchanged 82nd Mean hemoglobin level of children aged 6-59 months 118 2019 up 0.9% 74th Estimated number of MDR/RR-TB incident cases 3,600 2024 down 26.5% 18th Neonatal mortality rate - Remains constant 3.94 2030 unchanged 145th Neonatal mortality rate - Current trends maintained 3.17 2030 down 16.7% 149th Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 24.8% 1st Neonatal mortality rate - SDG target met 3.17 2030 down 16.7% 149th Under 5 mortality rate - Remains constant 9.44 2030 unchanged 130th Under 5 mortality rate - Current trends maintained 8.14 2030 down 11.6% 129th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 39.9% 1st Under 5 mortality rate - SDG target met 8.14 2030 down 11.6% 129th Mortality rate age 10-19 - Remains constant 3.96 2030 down 3.3% 120th Mortality rate age 10-19 - Current trends maintained 3.7 2030 down 8.6% 121st Mortality rate age 10-19 - High-income country average rate matched 2.58 2030 down 31.8% 130th Neonatal deaths - Remains constant 1,527 2030 down 2.0% 88th Neonatal deaths - Current trends maintained 1,226 2030 down 18.4% 88th Neonatal deaths - SDG target met 1,226 2030 down 18.4% 83rd Under-five deaths - Remains constant 3,646 2030 down 4.4% 77th Under-five deaths - Current trends maintained 3,144 2030 down 15.5% 75th Under-five deaths - SDG target met 3,144 2030 down 15.5% 72nd Deaths age 10 to 19 - Remains constant 1,622 2030 up 11.2% 70th Deaths age 10 to 19 - Current trends maintained 1,456 2030 up 1.7% 70th Mortality caused by road traffic injury 12.7 per 100,000 population 2019 down 50.4% 109th Mortality caused by road traffic injury, female 7.2 per 100,000 female population 2019 down 46.3% 87th Mortality caused by road traffic injury, male 18.5 per 100,000 male population 2019 down 52.1% 112th Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd Ipv vaccine coverage 99 2024 unchanged 1st Number of births in thousands 395.03 2025 down 3.0% 16th Tb patients living with hiv receiving art 581 2021 up 1,715.6% 46th HIV-positive TB patients on ART (antiretroviral therapy) 87.0% 2024 up 14.5% 102nd Hospital beds 65.43 2020 down 7.5% 13th Treatment success rate for patients treated for MDR-TB 84.0% 2022 up 15.1% 38th New leprosy case detection rate per 1 000 000 population 0 2024 — 124th Treatment success rate: HIV-positive TB cases 76 2023 up 28.8% 69th Prevalence of wasting, weight for height 3.1% 2015 down 36.7% 64th Bladder cancer death rate 0.9583 2023 down 43.0% 82nd Cancer death rates by type who db 0.9583 2023 down 43.0% 82nd Weight-for-height <-2 SD 3.1 2015 down 36.5% 65th Sex ratio at birth 1.06 2024 unchanged 17th Crude birth rate 19.52 2024 down 15.2% 12th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 54.0% 2025 — 148th International Health Regulations core capacity scores, SPAR version 80 2025 — 25th Prevalence of underweight, weight for age 2.0% 2015 down 59.2% 87th Leprosy registered prevalence rate per 1 000 000 population 0 2024 — 121st ← Previous Page 17 of 23 Next →